FINAL EVALUATION OF 955 HCV PATIENTS TREATED WITH 12 WEEK REGIMENS CONTAINING SOFOSBUVIR plus /- SIMEPREVIR IN THE TRIO NETWORK: ACADEMIC AND COMMUNITY TREATMENT OF A REAL-WORLD, HETEROGENEOUS POPULATION

被引：13

作者：

Dieterich, D. ^{[1
]}

Bacon, B. ^{[2
]}

Flamm, S. ^{[3
]}

Kowdley, K. ^{[4
]}

Milligan, S. ^{[5
]}

Tsai, N. ^{[6
]}

Younossi, Z. ^{[7
]}

Lawitz, E. ^{[8
]}

机构：

[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[2] St Louis Univ, Sch Med, St Louis, MO 63103 USA

[3] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA

[4] Swedish Med Ctr, Liver Care Network, Seattle, WA USA

[5] Trio Hlth Analyt, Newton, MA USA

[6] Univ Hawaii, Queens Med Ctr, Honolulu, HI 96822 USA

[7] Inova Fairfax Hosp, Dept Med, Ctr Liver Dis, Falls Church, VA USA

[8] Univ Texas Hlth Sci Ctr San Antonio, Texas Liver Inst, San Antonio, TX 78229 USA

来源：

关键词：

D O I：

10.1016/S0168-8278(15)30978-8

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P0775

引用

页码：S621 / S621

页数：1